drugset / Trial / NCT01312311
Weekly Docetaxel Plus Cisplatin as the First-line Therapy for Nasopharyngeal Cancer
NaSingle-groupOpen-labelTreatment
Summary
The investigators will evaluate weekly docetaxel plus 3-weekly cisplatin regimen as the first-line therapy for recurrent of metastatic nasophayngeal cancer
Timeline
- Start
- 2006-07
- Primary completion
- 2011-05
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 70 mg/m2 | — |
| Subject | Docetaxel | Small molecule | 35 mg/m2 | — |